Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cancer Ther ; 6(3): 876-85, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17363482

ABSTRACT

Intracellular porphyrin generation following administration of 5-aminolaevulinic acid (5-ALA) has been widely used in photodynamic therapy. However, cellular uptake of 5-ALA is limited by its hydrophilicity, and improved means of delivery are therefore being sought. Highly branched polymeric drug carriers known as dendrimers present a promising new approach to drug delivery because they have a well-defined structure capable of incorporating a high drug payload. In this work, a dendrimer conjugate was investigated, which incorporated 18 aminolaevulinic acid residues attached via ester linkages to a multipodent aromatic core. The ability of the dendrimer to deliver and release 5-ALA intracellularly for metabolism to the photosensitizer, protoporphyrin IX, was studied in the transformed PAM 212 murine keratinocyte and A431 human epidermoid carcinoma cell lines. Up to an optimum concentration of 0.1 mmol/L, the dendrimer was significantly more efficient compared with 5-ALA for porphyrin synthesis. The intracellular porphyrin fluorescence levels showed good correlation with cellular phototoxicity following light exposure, together with minimal dark toxicity. Cellular uptake of the dendrimer occurs through endocytic routes predominantly via a macropinocytosis pathway. In conclusion, macromolecular dendritic derivatives are capable of delivering 5-ALA efficiently to cells for sustained porphyrin synthesis.


Subject(s)
Aminolevulinic Acid/administration & dosage , Carcinoma, Squamous Cell/drug therapy , Dendrimers/chemistry , Keratinocytes/drug effects , Photochemotherapy , Photosensitizing Agents/administration & dosage , Skin Neoplasms/drug therapy , Aminolevulinic Acid/chemistry , Animals , Carcinoma, Squamous Cell/metabolism , Cell Survival/drug effects , Cells, Cultured/drug effects , Humans , Keratinocytes/metabolism , Macromolecular Substances , Mice , Microscopy, Fluorescence , Molecular Structure , Photosensitizing Agents/chemistry , Protoporphyrins/analysis , Protoporphyrins/metabolism , Skin Neoplasms/metabolism , Structure-Activity Relationship
2.
Int J Biochem Cell Biol ; 38(8): 1382-92, 2006.
Article in English | MEDLINE | ID: mdl-16546435

ABSTRACT

Intracellular porphyrin generation following administration of 5-aminolaevulinic acid has been widely used in photodynamic therapy for a range of malignant and certain non-malignant lesions. However, cellular uptake of 5-aminolaevulinic acid is limited by its hydrophilic nature and improved means of delivery are therefore being sought. Highly branched polymeric drug carriers known as dendrimers are a promising new approach to drug delivery. The aim of this study was to investigate the efficacy of dendrimers conjugated with 5-aminolaevulinic acid for porphyrin production in the transformed PAM 212 keratinocyte cell line and skin explants. Each dendritic derivative incorporated three 5-aminolaevulinic acid residues which were conjugated as esters via methyl or propyl linkers to a central tertiary carbon whose remaining terminal bore an amino, aminobenzyloxycarbonyl or nitro group. In the cell line, all compounds were more efficient at low concentrations compared to equimolar 5-aminolaevulinic acid for porphyrin production, with the most efficient incorporating the longer propyl linker. This compound was also the most lipophilic according to partition coefficient measurements. The intracellular porphyrin fluorescence levels showed good correlation with cellular phototoxicity following light exposure for all the compounds, together with minimal dark toxicity. Our findings indicate that the key factors influencing the efficacy of the dendritic derivatives are lipophilicity and steric hindrance within the dendritic structure which could restrict access to intracellular esterases for liberation of 5-aminolaevulinic acid. These findings should be taken into account in the design of larger dendrimers of 5-aminolaevulinic acid.


Subject(s)
Aminolevulinic Acid/chemistry , Dendrimers/chemistry , Keratinocytes/drug effects , Photosensitizing Agents/pharmacology , Porphyrins/metabolism , Skin/drug effects , Animals , Cell Line, Transformed , Dose-Response Relationship, Drug , Female , In Vitro Techniques , Keratinocytes/cytology , Keratinocytes/metabolism , Mice , Microscopy, Fluorescence , Molecular Structure , Photochemotherapy/methods , Photosensitizing Agents/chemical synthesis , Photosensitizing Agents/chemistry , Porphyrins/analysis , Prodrugs/chemical synthesis , Prodrugs/chemistry , Prodrugs/pharmacology , Protoporphyrins/analysis , Protoporphyrins/metabolism , Rats , Rats, Sprague-Dawley , Skin/metabolism , Spectrometry, Fluorescence , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...